{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:45:01Z","timestamp":1789728301006,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,7,15]],"date-time":"2012-07-15T00:00:00Z","timestamp":1342310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/ng.2350","type":"journal-article","created":{"date-parts":[[2012,7,15]],"date-time":"2012-07-15T22:40:40Z","timestamp":1342392040000},"page":"861-871","source":"Crossref","is-referenced-by-count":65,"title":["The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells"],"prefix":"10.1038","volume":"44","author":[{"given":"Haojian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiguo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Con","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Cerny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Brehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,15]]},"reference":[{"key":"BFng2350_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrc1592","volume":"5","author":"BJ Huntly","year":"2005","unstructured":"Huntly, B.J. & Gilliland, D.G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat. Rev. Cancer 5, 311\u2013321 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"BFng2350_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya, T., Morrison, S.J., Clarke, M.F. & Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature 414, 105\u2013111 (2001).","journal-title":"Nature"},{"key":"BFng2350_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader, J.E. & Lindeman, G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755\u2013768 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"BFng2350_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.tcb.2005.07.004","volume":"15","author":"JC Wang","year":"2005","unstructured":"Wang, J.C. & Dick, J.E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 15, 494\u2013501 (2005).","journal-title":"Trends Cell Biol."},{"key":"BFng2350_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y Chen","year":"2009","unstructured":"Chen, Y., Hu, Y., Zhang, H., Peng, C. & Li, S. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat. Genet. 41, 783\u2013792 (2009).","journal-title":"Nat. Genet."},{"key":"BFng2350_CR6","doi-asserted-by":"publisher","first-page":"16870","DOI":"10.1073\/pnas.0606509103","volume":"103","author":"Y Hu","year":"2006","unstructured":"Hu, Y. et al. Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. Proc. Natl. Acad. Sci. USA 103, 16870\u201316875 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng2350_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo, J.V. & Barnes, D.J. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat. Rev. Cancer 7, 441\u2013453 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"BFng2350_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R Ren","year":"2005","unstructured":"Ren, R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat. Rev. Cancer 5, 172\u2013183 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"BFng2350_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","volume":"22","author":"S Wong","year":"2004","unstructured":"Wong, S. & Witte, O.N. The BCR-ABL story: bench to bedside and back. Annu. Rev. Immunol. 22, 247\u2013306 (2004).","journal-title":"Annu. Rev. Immunol."},{"key":"BFng2350_CR10","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker, B.J. et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031\u20131037 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFng2350_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJMoa011573","volume":"346","author":"H Kantarjian","year":"2002","unstructured":"Kantarjian, H. et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N. Engl. J. Med. 346, 645\u2013652 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFng2350_CR12","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa055229","volume":"354","author":"M Talpaz","year":"2006","unstructured":"Talpaz, M. et al. Dasatinib in imatinib-resistant Philadelphia chromosome\u2013positive leukemias. N. Engl. J. Med. 354, 2531\u20132541 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFng2350_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham, S.M. et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99, 319\u2013325 (2002).","journal-title":"Blood"},{"key":"BFng2350_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin, A.S. et al. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J. Clin. Invest. 121, 396\u2013409 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFng2350_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature01572","volume":"423","author":"J Lessard","year":"2003","unstructured":"Lessard, J. & Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255\u2013260 (2003).","journal-title":"Nature"},{"key":"BFng2350_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature01587","volume":"423","author":"IK Park","year":"2003","unstructured":"Park, I.K. et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302\u2013305 (2003).","journal-title":"Nature"},{"key":"BFng2350_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/ni893","volume":"4","author":"K Saijo","year":"2003","unstructured":"Saijo, K. et al. Essential role of Src-family protein tyrosine kinases in NF-\u03baB activation during B cell development. Nat. Immunol. 4, 274\u2013279 (2003).","journal-title":"Nat. Immunol."},{"key":"BFng2350_CR18","doi-asserted-by":"crossref","first-page":"15310","DOI":"10.1016\/S0021-9258(17)36607-3","volume":"269","author":"P Zwollo","year":"1994","unstructured":"Zwollo, P. & Desiderio, S. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell\u2013specific activator protein. J. Biol. Chem. 269, 15310\u201315317 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFng2350_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/44076","volume":"401","author":"SL Nutt","year":"1999","unstructured":"Nutt, S.L., Heavey, B., Rolink, A.G. & Busslinger, M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401, 556\u2013562 (1999).","journal-title":"Nature"},{"key":"BFng2350_CR20","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1038\/sj.onc.1205942","volume":"21","author":"S Xie","year":"2002","unstructured":"Xie, S., Lin, H., Sun, T. & Arlinghaus, R.B. Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene 21, 7137\u20137146 (2002).","journal-title":"Oncogene"},{"key":"BFng2350_CR21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0092-8674(92)90241-4","volume":"70","author":"CL Sawyers","year":"1992","unstructured":"Sawyers, C.L., Callahan, W. & Witte, O.N. Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70, 901\u2013910 (1992).","journal-title":"Cell"},{"key":"BFng2350_CR22","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1182\/blood-2005-09-3732","volume":"107","author":"M Notari","year":"2006","unstructured":"Notari, M. et al. A MAPK\/HNRPK pathway controls BCR\/ABL oncogenic potential by regulating MYC mRNA translation. Blood 107, 2507\u20132516 (2006).","journal-title":"Blood"},{"key":"BFng2350_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1074-7613(00)80078-3","volume":"11","author":"M O'Riordan","year":"1999","unstructured":"O'Riordan, M. & Grosschedl, R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11, 21\u201331 (1999).","journal-title":"Immunity"},{"key":"BFng2350_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/376263a0","volume":"376","author":"H Lin","year":"1995","unstructured":"Lin, H. & Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263\u2013267 (1995).","journal-title":"Nature"},{"key":"BFng2350_CR25","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1182\/blood-2008-01-129049","volume":"112","author":"H Wang","year":"2008","unstructured":"Wang, H. et al. IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 112, 4028\u20134038 (2008).","journal-title":"Blood"},{"key":"BFng2350_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12026-008-8055-8","volume":"43","author":"H Wang","year":"2009","unstructured":"Wang, H. & Morse, H.C. III. IRF8 regulates myeloid and B lymphoid lineage diversification. Immunol. Res. 43, 109\u2013117 (2009).","journal-title":"Immunol. Res."},{"key":"BFng2350_CR27","doi-asserted-by":"publisher","first-page":"14028","DOI":"10.1073\/pnas.0506464102","volume":"102","author":"ZB Xia","year":"2005","unstructured":"Xia, Z.B. et al. The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression. Proc. Natl. Acad. Sci. USA 102, 14028\u201314033 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng2350_CR28","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1158\/0008-5472.CAN-04-1357","volume":"65","author":"EJ Andreu","year":"2005","unstructured":"Andreu, E.J. et al. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Cancer Res. 65, 3264\u20133272 (2005).","journal-title":"Cancer Res."},{"key":"BFng2350_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2006.11.049","volume":"128","author":"I Chu","year":"2007","unstructured":"Chu, I. et al. p27 phosphorylation by Src regulates inhibition of cyclin E\u2013Cdk2. Cell 128, 281\u2013294 (2007).","journal-title":"Cell"},{"key":"BFng2350_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cell.2006.11.047","volume":"128","author":"M Grimmler","year":"2007","unstructured":"Grimmler, M. et al. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128, 269\u2013280 (2007).","journal-title":"Cell"},{"key":"BFng2350_CR31","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/blood.V96.5.1933","volume":"96","author":"T Jonuleit","year":"2000","unstructured":"Jonuleit, T. et al. Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines. Blood 96, 1933\u20131939 (2000).","journal-title":"Blood"},{"key":"BFng2350_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/sj.leu.2403999","volume":"20","author":"J Rangatia","year":"2006","unstructured":"Rangatia, J. & Bonnet, D. Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation. Leukemia 20, 68\u201376 (2006).","journal-title":"Leukemia"},{"key":"BFng2350_CR33","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.1073\/pnas.96.17.9557","volume":"96","author":"H Oda","year":"1999","unstructured":"Oda, H., Kumar, S. & Howley, P.M. Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. Proc. Natl. Acad. Sci. USA 96, 9557\u20139562 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng2350_CR34","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrc2396","volume":"8","author":"D Frescas","year":"2008","unstructured":"Frescas, D. & Pagano, M. Deregulated proteolysis by the F-box proteins SKP2 and \u03b2-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8, 438\u2013449 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"BFng2350_CR35","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1182\/blood-2007-09-113860","volume":"112","author":"A Agarwal","year":"2008","unstructured":"Agarwal, A. et al. Absence of SKP2 expression attenuates BCR-ABL\u2013induced myeloproliferative disease. Blood 112, 1960\u20131970 (2008).","journal-title":"Blood"},{"key":"BFng2350_CR36","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1073\/pnas.0510423103","volume":"103","author":"JP Radich","year":"2006","unstructured":"Radich, J.P. et al. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc. Natl. Acad. Sci. USA 103, 2794\u20132799 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng2350_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","volume":"17","author":"B Zhang","year":"2010","unstructured":"Zhang, B. et al. Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell 17, 427\u2013442 (2010).","journal-title":"Cancer Cell"},{"key":"BFng2350_CR38","doi-asserted-by":"publisher","first-page":"798592","DOI":"10.1155\/2011\/798592","volume":"2011","author":"M Affer","year":"2011","unstructured":"Affer, M. et al. Gene expression differences between enriched normal and chronic myelogenous leukemia quiescent stem\/progenitor cells and correlations with biological abnormalities. J. Oncol. 2011, 798592 (2011).","journal-title":"J. Oncol."},{"key":"BFng2350_CR39","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1046\/j.1365-2141.1997.2823097.x","volume":"98","author":"RE Nordon","year":"1997","unstructured":"Nordon, R.E., Ginsberg, S.S. & Eaves, C.J. High-resolution cell division tracking demonstrates the FLt3-ligand-dependence of human marrow CD34+CD38\u2212 cell production in vitro. Br. J. Haematol. 98, 528\u2013539 (1997).","journal-title":"Br. J. Haematol."},{"key":"BFng2350_CR40","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1182\/blood-2008-06-164582","volume":"115","author":"NB Heaney","year":"2010","unstructured":"Heaney, N.B. et al. Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD\/SCID repopulating cells. Blood 115, 2241\u20132250 (2010).","journal-title":"Blood"},{"key":"BFng2350_CR41","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","volume":"101","author":"R Bhatia","year":"2003","unstructured":"Bhatia, R. et al. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 101, 4701\u20134707 (2003).","journal-title":"Blood"},{"key":"BFng2350_CR42","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","volume":"14","author":"C Dierks","year":"2008","unstructured":"Dierks, C. et al. Expansion of Bcr-Abl\u2013positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14, 238\u2013249 (2008).","journal-title":"Cancer Cell"},{"key":"BFng2350_CR43","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/ni1381","volume":"7","author":"P Kirstetter","year":"2006","unstructured":"Kirstetter, P., Anderson, K., Porse, B.T., Jacobsen, S.E. & Nerlov, C. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat. Immunol. 7, 1048\u20131056 (2006).","journal-title":"Nat. Immunol."},{"key":"BFng2350_CR44","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/ni1387","volume":"7","author":"M Scheller","year":"2006","unstructured":"Scheller, M. et al. Hematopoietic stem cell and multilineage defects generated by constitutive \u03b2-catenin activation. Nat. Immunol. 7, 1037\u20131047 (2006).","journal-title":"Nat. Immunol."},{"key":"BFng2350_CR45","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","volume":"12","author":"C Zhao","year":"2007","unstructured":"Zhao, C. et al. Loss of \u03b2-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12, 528\u2013541 (2007).","journal-title":"Cancer Cell"},{"key":"BFng2350_CR46","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao, C. et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458, 776\u2013779 (2009).","journal-title":"Nature"},{"key":"BFng2350_CR47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/leu.2008.262","volume":"23","author":"Y Hu","year":"2009","unstructured":"Hu, Y., Chen, Y., Douglas, L. & Li, S. \u03b2-catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL\u2013induced chronic myeloid leukemia. Leukemia 23, 109\u2013116 (2009).","journal-title":"Leukemia"},{"key":"BFng2350_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ng1343","volume":"36","author":"Y Hu","year":"2004","unstructured":"Hu, Y. et al. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1\u2013induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat. Genet. 36, 453\u2013461 (2004).","journal-title":"Nat. Genet."},{"key":"BFng2350_CR49","doi-asserted-by":"publisher","first-page":"33260","DOI":"10.1074\/jbc.272.52.33260","volume":"272","author":"M Warmuth","year":"1997","unstructured":"Warmuth, M. et al. The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr. J. Biol. Chem. 272, 33260\u201333270 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFng2350_CR50","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1182\/blood-2007-08-109330","volume":"111","author":"J Wu","year":"2008","unstructured":"Wu, J. et al. Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells. Blood 111, 3821\u20133829 (2008).","journal-title":"Blood"},{"key":"BFng2350_CR51","first-page":"924","volume":"118","author":"W Xiao","year":"2008","unstructured":"Xiao, W., Hong, H., Kawakami, Y., Lowell, C.A. & Kawakami, T. Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn\/Hck, SHIP, and Stat5. J. Clin. Invest. 118, 924\u2013934 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFng2350_CR52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ni1454","volume":"8","author":"C Cobaleda","year":"2007","unstructured":"Cobaleda, C., Schebesta, A., Delogu, A. & Busslinger, M. Pax5: the guardian of B cell identity and function. Nat. Immunol. 8, 463\u2013470 (2007).","journal-title":"Nat. Immunol."},{"key":"BFng2350_CR53","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan, C.G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758\u2013764 (2007).","journal-title":"Nature"},{"key":"BFng2350_CR54","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMoa0808253","volume":"360","author":"CG Mullighan","year":"2009","unstructured":"Mullighan, C.G. et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N. Engl. J. Med. 360, 470\u2013480 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFng2350_CR55","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/81335","volume":"6","author":"T Cheng","year":"2000","unstructured":"Cheng, T., Rodrigues, N., Dombkowski, D., Stier, S. & Scadden, D.T. Stem cell repopulation efficiency but not pool size is governed by p27kip1. Nat. Med. 6, 1235\u20131240 (2000).","journal-title":"Nat. Med."},{"key":"BFng2350_CR56","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1158\/0008-5472.CAN-03-3656","volume":"64","author":"P Ramaraj","year":"2004","unstructured":"Ramaraj, P. et al. Effect of mutational inactivation of tyrosine kinase activity on BCR\/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors. Cancer Res. 64, 5322\u20135331 (2004).","journal-title":"Cancer Res."},{"key":"BFng2350_CR57","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1182\/blood-2007-09-112573","volume":"111","author":"M Copland","year":"2008","unstructured":"Copland, M. et al. BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors. Blood 111, 2843\u20132853 (2008).","journal-title":"Blood"},{"key":"BFng2350_CR58","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","volume":"189","author":"S Li","year":"1999","unstructured":"Li, S., Ilaria, R.L. Jr., Million, R.P., Daley, G.Q. & Van Etten, R.A. The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia\u2013like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189, 1399\u20131412 (1999).","journal-title":"J. Exp. Med."},{"key":"BFng2350_CR59","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood-2006-10-054098","volume":"110","author":"C Peng","year":"2007","unstructured":"Peng, C. et al. Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I\u2013induced leukemia and suppresses leukemic stem cells. Blood 110, 678\u2013685 (2007).","journal-title":"Blood"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng.2350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.2350","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.2350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:48:57Z","timestamp":1684442937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng.2350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,15]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["BFng2350"],"URL":"https:\/\/doi.org\/10.1038\/ng.2350","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,15]]}}}